Continue reading this on our app for a better experience

Open in App
Home News Covid-19

BioNTech gets downgrade from analyst amid vaccine competition

Bloomberg
Bloomberg • 1 min read
BioNTech gets downgrade from analyst amid vaccine competition
A BioNTech SE analyst advised investors to cash in on their profits from the US$30 billion biotech’s recent advance.
Font Resizer
Share to Whatsapp
Share to Facebook
Share to LinkedIn
Scroll to top
Follow us on Facebook and join our Telegram channel for the latest updates.
×
Loading next article...
The Edge Singapore
Download The Edge Singapore App
Google playApple store play
Keep updated
Follow our social media
© 2024 The Edge Publishing Pte Ltd. All rights reserved.